-
UCB's innovative treatment for psoriasis obtains EU approval
Time of Update: 2021-09-12
Recently, UCB announced that the European Commission has approved the company's development of Bimzelx (bimekizumab) for the treatment of patients with moderate to severe plaque psoriasis suitable for systemic treatment .
from https:// Press-Releases/article/UCB-Announces-European-Commission-Approval-of-BIMZELX-bimekizumab-for-the-Treatment-of-Adults-with-Moderate-to-Severe-Plaque-Psoriasis [2] Bimekizumab Overview.
-
Goserelin microsphere preparation phase III clinical success, the market of billions of large varieties is about to be reshuffled!
Time of Update: 2021-09-12
On September 6, Luye Pharma announced that its self-developed anti-tumor innovative preparations for injection of Goserelin Acetate Sustained Release Microspheres (LY01005) has completed a phase III clinical study for the treatment of prostate cancer in China, reaching the preset end point.
-
With a layout of more than 3 billion US dollars, why is this type of cell therapy favored by Roche?
Time of Update: 2021-09-10
So what is the difference between it and cell therapy using primary cells?The use of iPSC to generate natural killer (NK) cells, T cells and macrophages has become a hot spot in the field of cell therapy development in recent years Advantages of iPSC Generating Cell TherapyAdvantages of iPSC Generating Cell Therapy At present, many CAR-T therapies have obtained regulatory approval to treat patients with different blood cancers .
-
Significantly improve multiple health and functional indicators, subcutaneous injection of RNAi therapy announced the latest phase 3 trial results
Time of Update: 2021-09-10
Retrieved September 7, 2021, from https:// home/20210907005432/en[1] Alnylam Presents Additional 9-Month Data from HELIOS-A Phase 3 Study of Vutrisiran at the European ATTR (EU-ATTR) Amyloidosis Meeting.
-
Development of mRNA therapy for genetic metabolic diseases Moderna reached cooperation
Time of Update: 2021-09-10
from https:// news/home/20210907005534/en/[1] Moderna and the Institute for Life Changing Medicines Announce a New Collaboration to Develop an mRNA Therapeutic for Ultra-Rare Disease, Crigler-Najjar Syndrome Type 1.
-
"Hing Zong" or "Lian Heng"?
Time of Update: 2021-09-10
On the one hand, they can promote the improvement of the R&D level of domestic pharmaceutical companies and achieve integration with international standards; on the other hand, after innovative drug products are approved for marketing in developed countries, they can use foreign partners The marketing team and channels to accelerate the speed of innovation and return .
-
Comparison of Chinese, Japanese and Korean medicine BD transactions
Time of Update: 2021-09-10
China, Japan and South Korea enterprise drug license in transaction top3 Top3 of drug license out transactions for Chinese, Japanese and Korean companies The total market value of Chinese pharmaceutical companies currently ranks second in the world and first in Asia.
-
Ascent Pharmaceuticals APG-1252 won an oral report at the 2021 World Lung Cancer Conference, revealing the potential of combining osimertinib in the treatment of drug-resistant non-small cell lung cancer
Time of Update: 2021-09-10
06 SpecialSpecial New drugs and targeted therapies Novel Therapeutics and Targeted Therapies timetime China Time: September 9th 00:05 – 00:10 Mountain time: September 8th 10:05 – 10:10 Key InformationKey Information This is a single-arm, multi-center, phase Ib study of APG-1252 combined with osimertinib in the treatment of patients with advanced EGFR mutation-positive NSCLC, including dose exploration and dose expansion .
-
2021 Service Trade Fair concludes its first show in Beijing's health section, fruitful results
Time of Update: 2021-09-10
On September 7, the 2021 China International Service Trade Fair (hereinafter referred to as the "Service Trade Fair") closed in Beijing . The health section hosted by the China Pharmaceutical Inno
-
Hutchison Medicine will announce the latest clinical data of 3 anticancer drugs at ESMO Annual Meeting
Time of Update: 2021-09-10
And the male Buao Xi Huang medicine imatinib and who Wolfowitz interim analysis of study results ORCHARD erlotinib combination therapy of advanced progression after first-line treatment of diseases Osh imatinib non-small cell lung cancer patients Fruquintinib is a highly selective and potent oral inhibitor of vascular endothelial growth factor receptor (VEGFR) 1, 2 and 3 .
-
2021H1: A collection of R&D expenses of domestic and foreign pharmaceutical companies
Time of Update: 2021-09-10
581 billion yuan in research and development in the first half of the year, an increase of 38% compared with the same period last year, accounting for 19% of revenue; during the reporting period, innovative drugs achieved sales revenue of 5.
-
The hundreds of billions market was hit hard!
Time of Update: 2021-09-10
According to data from Mi Nei. com, in 2020, the sales of terminal anti-tumor drugs in China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) exceeded 100 billion yuan, an increase of 9.
-
What are the uses of sulfamethoxazole?
Time of Update: 2021-09-05
Sulfamethoxazole is an antibacterial agent that is very effective against Staphylococcus aureus and Escherichia coli .
After use, it can hinder the growth of bacteria, especially for Staphylococcus and Escherichia coli has a strong effect .
-
Introduction to all aspects of rifaximin drugs
Time of Update: 2021-09-05
Rifaximin is a drug that can treat physical diseases.
Patients can choose different types of drugs to treat physical problems according to their actual medication needs.
Furthermore, the efficacy of this drug is mainly suitable for intestinal problems caused by pathogens sensitive to rifaximin.
-
Adverse reactions in pregnant women taking perampanel
Time of Update: 2021-09-05
It brings risks to the normal development of newborns, and can also cause the symptoms of children to stop developing or women to stop breastfeeding.
-
Are norfloxacin tablets an antibiotic? What are the points to note?
Time of Update: 2021-09-05
Although the use of antibiotics is persuaded to bring certain side effects to the body, if the disease caused by bacterial infection is still more effective through the treatment of antibiotics, then is norfloxacin tablets an antibiotic?
This drug is aimed at a variety of inflammatory diseases and can also have a good therapeutic effect.
-
What are the price and precautions of roxithromycin
Time of Update: 2021-09-05
To take it according to the instructions, what are the prices and precautions of roxithromycin?
To ensure the quality of the product, many patients can eliminate inflammation in the body after taking roxithromycin.
What is the price and precautions of roxithromycin ?
-
Basic information on the physical chemistry of vinflunine tartrate
Time of Update: 2021-09-05
Medicine, then what are the basic information about the physical chemistry of vinflunine tartrate ?
What are the basic information about the physical chemistry of vinflunine tartrate ?
-
What are the main uses of Azilsartan medoxomil potassium salt
Time of Update: 2021-09-05
Azilsartan medoxomil potassium salt is a drug developed by foreign scientists.
Go to the hospital regularly to measure high blood pressure to avoid the symptoms of low pressure during the period of taking medicines .
-
What are the symptoms of folic acid deficiency in the body
Time of Update: 2021-09-05
A large number of scientific experiments have shown that if the mother does not supplement folic acid in time during pregnancy, it can also cause the symptoms of cleft lip .
Therefore, it is recommended that pregnant women take folic acid in time in daily life.
